tiprankstipranks
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
US Market

Tevogen Bio Holdings (TVGN) Income Statement

Compare
266 Followers

Tevogen Bio Holdings Income Statement

Last quarter (Q3 2024), Tevogen Bio Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tevogen Bio Holdings's net income was $-5.88M. See Tevogen Bio Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.27M$ 953.08K$ 4.62M
Depreciation and Amortization
$ 197.55K$ 230.82K$ 9.38K
EBITDA
$ 188.71K$ -953.08K$ -28.75K
Operating Income
-$ -13.72M$ -4.62M
Other Income/Expenses
-$ 4.42M-
Pretax Income
$ -67.33K$ 4.41M$ -15.60M
Net Income
$ -67.33K$ 4.41M$ -15.60M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ 0.00$ 0.04$ -0.13
Diluted EPS
$ 0.00$ 0.04$ -0.13
Weighted Average Shares Outstanding
165.42M 120.00M 120.00M
Weighted Average Shares Outstanding (Diluted)
165.42M 120.00M 120.00M
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis